Patent · US Expired

Influenza virus vaccine composition

US6372223B1 · kind B1 · utility

35Cited by

0References

8Claims

0Family size

Assignee

Baxter Aktiengesellschaft · AT

Inventors

Otfried Kistner · Wien, AT
Noel Barrett · Klosterneuburg, AT
Wolfgang Mundt · Wien, AT
Friedrich Dorner · Wien, AT

Key dates

Filing date	Jun 12, 2001
Grant date	Apr 16, 2002
Priority date	—
Expiry date	Jun 12, 2021

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16234
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention describes an influenza virus vaccine containing an influenza virus antigen obtained from a cell culture, with an influenza virus antigen content between 1 &mgr;g and 5 &mgr;g per dose and aluminum as an adjuvant as well as a method for its preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.